5 EASY FACTS ABOUT AGO TUMOR DESCRIBED

Molecular typing relies on molecular genetic screening and isn't however routinely out there. Molecular subtypes and immunohistochemical surrogate markers of the tumors (HR, HER2, triple negative) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and proliferation markers like Ki-67 may very well be practical, b